Cipla develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression and cardiovascular diseases.Read more
Cipla's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 6.7B. Over the last four quarters, Cipla's revenue has decreased by 6.5%. Specifically, in Q2 2022's revenue was $694.6M; in Q1 2022, it was $727.5M; in Q4 2021, it was $693.7M; in Q3 2021, Cipla's revenue was $743M.
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel
222-482-6000Driving Directions »